Apathy associated with neurocognitive disorders: Recent progress and future directions

详细信息    查看全文

• 作者：Krista L. Lanctô ; t^a ; ^b ; ^c ; ^{krista.lanctot@sunnybrook.ca} ; Luis Agü ; era-Ortiz^d ; ^e ; Henry Brodaty^f ; Paul T. Francis^g ; Yonas E. Geda^h ; ⁱ ; ^j ; Zahinoor Ismail^k ; ^l ; Gad A. Marshall^m ; Moyra E. Mortbyⁿ ; ^o ; Chiadi U. Onyike^p ; Prasad R. Padala^q ; ^r ; Antonios M. Politis^s ; Paul B. Rosenberg^t ; Emma Siegel^f ; David L. Sultzer^u ; Eleenor H. Abraham^a
• 关键词：Apathy ; Alzheimer's disease (AD) ; Mild behavioral impairment (MBI) ; neuropsychiatric symptoms (NPS) ; Neurocognitive disorders (NCD)
• 刊名：Alzheimer's & Dementia
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：13
• 期：1
• 页码：84-100
• 全文大小：536 K
• 卷排序：13

文摘

Apathy is common in neurocognitive disorders (NCDs) such as Alzheimer's disease and mild cognitive impairment. Although the definition of apathy is inconsistent in the literature, apathy is primarily defined as a loss of motivation and decreased interest in daily activities.MethodsThe Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Neuropsychiatric Syndromes Professional Interest Area (NPS-PIA) Apathy workgroup reviewed the latest research regarding apathy in NCDs.ResultsProgress has recently been made in three areas relevant to apathy: (1) phenomenology, including the use of diagnostic criteria and novel instruments for measurement, (2) neurobiology, including neuroimaging, neuropathological and biomarker correlates, and (3) interventions, including pharmacologic, nonpharmacologic, and noninvasive neuromodulatory approaches.DiscussionRecent progress confirms that apathy has a significant impact on those with major NCD and those with mild NCDs. As such, it is an important target for research and intervention.